- Public Comps
- Aclarion
Aclarion Valuation Multiples
Discover revenue and EBITDA valuation multiples for Aclarion and similar public comparables like NRGene, Pheton Holdings, HeartSciences, AMA Corp and more.
Aclarion Overview
About Aclarion
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
Founded
2015
HQ

Employees
6
Website
Financials (LTM)
Market Cap
$8M
Valuation Multiples
Start free trialAclarion Financials
Aclarion reported last 12-month revenue of $116K.
In the same LTM period, Aclarion generated $34K in gross profit and had net loss of ($9M).
Aclarion P&L
In the most recent fiscal year, Aclarion reported revenue of $76K and EBITDA of ($7M).
Aclarion is unprofitable as of last fiscal year, with gross margin of 9%, EBITDA margin of (9794%), and net margin of (9552%).
Financial data powered by Morningstar, Inc.
Aclarion Stock Performance
Aclarion has current market cap of $8M.
Market Cap Evolution
Aclarion's stock price is $2.74.
Aclarion has an EPS (earnings per share) of $-2.51.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $8M | 11.4% | - | - | - | $-2.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAclarion Valuation Multiples
Aclarion trades at (72.1x) EV/Revenue multiple, and 1.1x EV/EBITDA.
Aclarion Financial Valuation Multiples
As of August 18, 2026, Aclarion has market cap of $8M.
Aclarion has a P/E ratio of (0.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Aclarion Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Aclarion Margins & Growth Rates
Aclarion grew revenue by 85% and net profit by 48% in the last fiscal year.
In the most recent fiscal year, Aclarion reported gross margin of 9%, EBITDA margin of (9794%), and net margin of (9552%).
Aclarion Margins
Aclarion Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Aclarion Operational KPIs
Aclarion's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Aclarion Competitors
Aclarion competitors include NRGene, Pheton Holdings, HeartSciences, AMA Corp, Media Lab, Predilife, Synthetic MR, Kontigo Care, Servana and CurveBeam AI.
Most Aclarion public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, Vertical SaaS, HealthTech and Longevity.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.7x | - | (2.4x) | - | |||
| - | - | - | - | |||
| 2523.4x | - | (1.3x) | (1.5x) | |||
| 4.2x | - | (1.7x) | - | |||
| 4.1x | - | 17.8x | - | |||
| 13.0x | - | (3.4x) | - | |||
| 0.4x | 0.4x | (0.6x) | (1.8x) | |||
| 1.3x | - | 10.8x | - | |||
This data is available for Pro users. Sign up to see all Aclarion competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Aclarion
| When was Aclarion founded? | Aclarion was founded in 2015. |
| Where is Aclarion headquartered? | Aclarion is headquartered in United States. |
| How many employees does Aclarion have? | As of today, Aclarion has over 6 employees. |
| Is Aclarion publicly listed? | Yes, Aclarion is a public company listed on Nasdaq. |
| What is the stock symbol of Aclarion? | Aclarion trades under ACON ticker. |
| When did Aclarion go public? | Aclarion went public in 2022. |
| Who are competitors of Aclarion? | Aclarion main competitors include NRGene, Pheton Holdings, HeartSciences, AMA Corp, Media Lab, Predilife, Synthetic MR, Kontigo Care, Servana, CurveBeam AI. |
| What is the current market cap of Aclarion? | Aclarion's current market cap is $8M. |
| What is the current revenue of Aclarion? | Aclarion's last 12 months revenue is $116K. |
| What is the current revenue growth of Aclarion? | Aclarion revenue growth (NTM/LTM) is 85%. |
| What is the current EV/Revenue multiple of Aclarion? | Current revenue multiple of Aclarion is (72.1x). |
| Is Aclarion profitable? | No, Aclarion is not profitable. |
| What is the current net income of Aclarion? | Aclarion's last 12 months net income is ($9M). |
| How many companies Aclarion has acquired to date? | Aclarion hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Aclarion has invested to date? | Aclarion hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Aclarion
Lists including Aclarion
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




